Table 3.
Metrics for safety and clinical outcome
Clinical outcome measures | |
---|---|
Mortality (%) | 15 (21.1 %) |
New-onset organ dysfunction | Cardiovascular 6 (8.4 %) |
Respiratory 1 (1.4 %) | |
Renal 5 (7.0 %) | |
New-onset Sepsis | 10 (14.1 %) |
Gastrointestinal fistula | 17 (23.9 %) |
Colonic alone 7 (9.9 %) | |
Duodenal alone 5 (7.0 %) | |
Jejunal or gastric alone 1 (1.4 %) | |
Multiple 4 (5.6) | |
Pancreatic fistula | 14 (19.7 %) |
Chylous fistula | 3 (4.2 %) |
Intra-abdominal bleeding | 11 (15.5 %) |
Portal venous system thrombosis | 3 (4.2 %) |
Positive culture result for fungi | 12 (16.9 %) |
Gastric outlet obstruction | 2 (2.8 %) |
Hospital duration (day) | 41 (23–61) |
ICU duration (day) | 17 (7–43) |
Total cost (10,000 rmb) | 18.2 (8.6–32.4) |